Recipharm snags $114 million loan, says it's shopping

Recipharm has gotten it hands on some extra money and is out shopping for companies it can buy to expand its contract manufacturing. The company says it obtained a 5-year, €90 million ($114 million) loan from Swedbank AB earlier this week and plans to expand its contract manufacturing and development business. The Sweden-based company says in a release that it plans to build current operations and continue its plan of "strategic acquisitions."  While it does not specify who might be targets, OutsourcingPharma reminds that CEO Thomas Eldered last year told the publication that Recipharm would like to participate in the growth in India and China. But then wouldn't everyone. Story | More

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.